A five year prospective study reveals that insulin glargine is as safe as NPH insulin with regard to developing diabetic retinopathy. Patients placed on insulin glargine are no more likely to develop diabetic retinopathy than Type II diabetics on NPH insulin.
The study also found that the severity of the diabetic retinopathy was similar in the two groups.
Read the article.
Randy
Randall V. Wong, M.D.
Ophthalmologist, Retina Specialist
www.TotalRetina.com
